Accelerate Diagnostics (NASDAQ:AXDX) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Accelerate Diagnostics beat estimated earnings by 16.67%, reporting an EPS of $-0.25 versus an estimate of $-0.3.
Revenue was up $440.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 7.93% drop in the share price the next day.
Here's a look at Accelerate Diagnostics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.25 | -0.33 | -0.33 | -0.33 |
| EPS Actual | -0.23 | -0.31 | -0.36 | -0.41 |
| Revenue Estimate | 3.70M | 3.91M | 3.07M | 3.10M |
| Revenue Actual | 3.30M | 3.12M | 2.80M | 2.52M |
To track all earnings releases for Accelerate Diagnostics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
